Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market.
Lithium has been used for over half a century for the treatment of bipolar disorder as the archetypal mood stabilizer, and has a wealth of empirical evidence supporting its efficacy in this role. Despite this, the specific mechanisms by which lithium exerts its mood-stabilizing effects are not well understood.
A: Lithium (Lithobid) is an antipsychotic mood stabilizer which is used to treat bipolar disorder and manic episodes of manic-depressive illness. Some of the most common side effects with lithium use include mild thirst, nausea, generalized discomfort, and mild tremor.